Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucose | 2 | 2018 | 217 | 0.270 |
Why?
|
| Hesperidin | 1 | 2018 | 5 | 0.170 |
Why?
|
| Glucosides | 1 | 2018 | 15 | 0.170 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 129 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2018 | 171 | 0.150 |
Why?
|
| Cisplatin | 1 | 2018 | 70 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 82 | 0.150 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2016 | 15 | 0.140 |
Why?
|
| Antioxidants | 1 | 2018 | 386 | 0.130 |
Why?
|
| Fructose | 1 | 2015 | 23 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 336 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 152 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 592 | 0.080 |
Why?
|
| Neoplasms | 1 | 2016 | 1033 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2018 | 212 | 0.040 |
Why?
|
| Mice | 2 | 2018 | 5668 | 0.040 |
Why?
|
| Cholesterol | 1 | 2018 | 194 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 217 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 323 | 0.040 |
Why?
|
| Animals | 3 | 2018 | 14307 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 649 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 52 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 897 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 161 | 0.030 |
Why?
|
| Rats, Inbred OLETF | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2015 | 21 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 27 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.030 |
Why?
|
| Weight Gain | 1 | 2015 | 128 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 287 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 120 | 0.030 |
Why?
|
| Adiposity | 1 | 2015 | 145 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 490 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 137 | 0.030 |
Why?
|
| Insulin | 1 | 2015 | 224 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2015 | 333 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2015 | 177 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 580 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1152 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 756 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 781 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1149 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 577 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2128 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1802 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 965 | 0.020 |
Why?
|
| Humans | 2 | 2018 | 34853 | 0.010 |
Why?
|
| Male | 1 | 2018 | 18870 | 0.010 |
Why?
|
| Female | 1 | 2018 | 19873 | 0.010 |
Why?
|